Prestige Consumer Healthcare (PBH) Assets Average (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Assets Average of $3.5 billion for Q4 2025, up 4.37% year-over-year from $3.3 billion in Q4 2024, and up 0.92% quarter-over-quarter from $3.4 billion in Q3 2025.
Prestige Consumer Healthcare (PBH) Assets Average (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Assets Average history runs 15 years deep, the most recent figure standing at $3.5 billion for Q4 2025.
- In Q4 2025, Assets Average rose 4.37% year-over-year to $3.5 billion; the TTM figure through Dec 2025 stood at $3.5 billion (up 4.37% YoY), while the FY2025 annual figure was $3.4 billion, up 0.73% from the prior year.
- Assets Average for Q4 2025 stood at $3.5 billion, up from $3.4 billion in the prior quarter.
- The five-year high for Assets Average was $3.7 billion in Q4 2022, with the low at $3.3 billion in Q3 2024.
- The 5-year median for Assets Average is $3.4 billion (2021), against an average of $3.5 billion.
- The sharpest annual moves came in 2022 and 2023: Assets Average climbed 6.26% in 2022, then declined 10.17% in 2023.
- Prestige Consumer Healthcare's Assets Average stood at $3.7 billion in 2021, then advanced by 1.27% to $3.7 billion in 2022, then declined by 10.17% to $3.3 billion in 2023, then retreated by 0.39% to $3.3 billion in 2024, then climbed by 4.37% to $3.5 billion in 2025.
- Business Quant data shows PBH's Assets Average at $3.5 billion in Q4 2025, $3.4 billion in Q3 2025, and $3.4 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | 3.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.49 Bn |
| Dec 31, 2025 | 3.47 Bn |
| Sep 30, 2025 | 3.44 Bn |
| Jun 30, 2025 | 3.42 Bn |
| Mar 31, 2025 | 3.37 Bn |
| Dec 31, 2024 | 3.32 Bn |
| Sep 30, 2024 | 3.31 Bn |
| Jun 30, 2024 | 3.31 Bn |
| Mar 31, 2024 | 3.33 Bn |
| Dec 31, 2023 | 3.34 Bn |
| Sep 30, 2023 | 3.34 Bn |
| Jun 30, 2023 | 3.35 Bn |
| Mar 31, 2023 | 3.55 Bn |
| Dec 31, 2022 | 3.71 Bn |
| Sep 30, 2022 | 3.68 Bn |
| Jun 30, 2022 | 3.68 Bn |
| Mar 31, 2022 | 3.67 Bn |
| Dec 31, 2021 | 3.67 Bn |
| Sep 30, 2021 | 3.62 Bn |
| Jun 30, 2021 | 3.49 Bn |